Federal Register / Vol. 83, No. 246 / Wednesday, December 26, 2018 / Notices 66265 

Construction Contract Administration, 

in all correspondence. 

Jeffrey A. Koses, 

Director, Office of Acquisition Policy, Office 

of Government-wide Policy. 

[FR Doc. 2018–27885 Filed 12–21–18; 8:45 am] 

BILLING CODE 6820–61–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substance and 

Disease Registry 

[60Day–19–19GW; Docket No. ATSDR– 

2018–0010] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Agency for Toxic Substances 

and Disease Registry (ATSDR), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Agency for Toxic 

Substances and Disease Registry 

(ATSDR), as part of its continuing effort 

to reduce public burden and maximize 

the utility of government information, 

invites the general public and other 

Federal agencies the opportunity to 

comment on a proposed and/or 

continuing information collection, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on ‘‘Exposure Characterization 

and Measurements during Activities 

Conducted on Synthetic Turf Fields 

with Tire Crumb Rubber Infill.’’ The 

purpose of the proposed study is to 

evaluate and characterize human 

exposure potential to select chemicals 

during play on synthetic turf fields with 

tire crumb rubber infill. 

DATES: ATSDR must receive written 

comments on or before February 25, 

2019. 

ADDRESSES: You may submit comments, 

identified by Docket No. ATSDR–2018– 

0010 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. ATSDR will post, 

without change, all relevant comments 

to Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffery M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), Federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires Federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses. 

5. Assess information collection costs. 

Proposed Project 

Exposure Characterization and 

Measurements during Activities 

Conducted on Synthetic Turf Fields 

with Tire Crumb Rubber Infill—New— 

Agency for Toxic Substances and 

Disease Registry (ATSDR). 

Background and Brief Description 

Currently in the United States, there 

are more than 12,000 synthetic turf 

fields in use. While the Synthetic Turf 

Council has set guidelines for the 

content of crumb rubber used as infill in 

synthetic turf fields, manufacturing 

processes result in differences among 

types of crumb rubber. Additionally, the 

chemical composition may vary highly 

between different processes and source 

materials and may vary even within 

granules from the same origin. 

The research protocol, Collections 

Related to Synthetic Turf Fields with 

Crumb Rubber Infill, has been 

conducted previously under two ICRs: 

Activity 1 under OMB Control No. 

0923–0054 (expiration date 01/31/2017) 

and Activities 2 and 3 under OMB 

Control No. 0923–0058 (expiration date 

08/13/2018). Activity 1 aimed to collect 

tire crumb rubber samples from 40 

synthetic turf fields across the US and 

from nine manufacturing facilities. 

Samples collection for Activity 1 was 

completed in November 2016. Activities 

2 and 3 aim to evaluate and characterize 

the human exposure potential to 

constituents in crumb rubber infill 

among a convenience sample of 60 field 

users (Activity 2) and to collect 

biological specimens (blood and urine) 

from 45 participants (Activity 3). During 

Activities 2 and 3, ATSDR and USEPA 

recruited and sampled a small number 

of field users in scheduled activities at 

fields that participated in Activity 1. 

However, the pilot scale study was 

limited in sample size and scope. 

The agencies are requesting a new 

information collection request (ICR) for 

a two-year PRA clearance to conduct a 

supplemental data collection, now titled 

‘‘Exposure Characterization and 

Measurements during Activities 

Conducted on Synthetic Turf Fields 

with Tire Crumb Rubber Infill’’. 

Preliminary results from the pilot scale 

study indicate the need for further 

investigation for a select group of 

chemicals to which field users may 

potentially be exposed. The proposed 

study will be a larger-scale assessment 

of exposure potential for individuals 

who use/play on synthetic turf fields 

with tire crumb rubber infill that will 

address key limitations; specifically, the 

sample size limitations in the pilot scale 

study and the lack of a comparison 

population. The study will include 

persons who use synthetic turf fields 

with crumb rubber infill (e.g., field 

users) and who routinely perform 

activities that would result in a high 

level of contact to crumb rubber. The 

study will also include persons who 

play on natural grass fields. Persons 


amozie on DSK3GDR082PROD with NOTICES1
66266 Federal Register / Vol. 83, No. 246 / Wednesday, December 26, 2018 / Notices 

who play on natural grass fields will 

provide a comparison group and allow 

for evaluation of exposures to 

constituents in tire crumb rubber among 

synthetic turf field users. 

The respondents will be administered 

a detailed questionnaire on activity 

patterns on synthetic turf with crumb 

rubber infill. This instrument will be 

used to characterize exposure scenarios, 

including the nature and duration of 

potential exposures. Additionally, the 

questionnaire will include queries on 

potential external sources, such as 

dietary sources, to select chemicals. We 

will collect urine samples pre- and postactivity. The urine samples will be 

analyzed for polyaromatic hydrocarbons 

and also archived for future analysis in 

the event of new analytical methods for 

potential chemicals of interest. 

The research study will screen a total 

of 220 participants for eligibility. The 

target sample size for synthetic turf field 

users is 150 and 50 for the natural grass 

field users. The total burden hours for 

the research study is 184 hours among 

all of the 220 respondents. There is no 

cost to the respondents other than their 

time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hrs.) 

Total burden 

(in hrs.) 

Adult/Adolescent Field Users ............ Eligibility Screening Form ................ 110 1 5/60 9 

Adult and Adolescent Questionnaire 100 1 30/60 50 

Exposure Measurement Form ......... 100 1 20/60 33 

Parents/Guardians of Youth/Child 

Field Users.

Eligibility Screening Form ................ 110 1 5/60 9 

Youth and Child Questionnaire ........ 100 1 30/60 50 

Youth/Child Field Users .................... Exposure Measurement Form ......... 100 1 20/60 33 

Total ........................................... ........................................................... ........................ ........................ ........................ 184 

Jeffrey M. Zirger, 

Acting Lead, Information Collection Review 

Office, Office of Scientific Integrity, Office 

of Science, Centers for Disease Control and 

Prevention. 

[FR Doc. 2018–27854 Filed 12–21–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Chief Operating Officer, CDC, 

pursuant to Public Law 92–463. The 

grant applications and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the grant applications, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)—DP19–004, 

Improving Detection and Management of 

Glaucoma and Other Eye Diseases Among 

High Risk Populations. 

Dates: March 26, 2019. 

Times: 10:00 a.m.–6:30 p.m., EDT. 

Place: Teleconference. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Jaya 

Raman Ph.D., Scientific Review Officer, CDC, 

4770 Buford Highway, Mailstop F80, Atlanta, 

Georgia 30341, Telephone: (770) 488–6511, 

kva5@cdc.gov. 

The Chief Operating Officer, Centers for 

Disease Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for both 

the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Sherri Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2018–27894 Filed 12–21–18; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Chief Operating Officer, CDC, 

pursuant to Public Law 92–463. The 

grant applications and the discussions 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the grant applications, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Disease, Disability, 

and Injury Prevention and Control Special 

Emphasis Panel (SEP)–PS19–001, The GAIN 

(Greater Access and Impact with NAT). 

Study: Improving HIV Diagnosis, Linkage 

to Care, and Prevention Services with HIV 

Point-of-Care Nucleic Acid Tests (NATs). 

Date: April 11, 2019. 

Time: 10:00 a.m.–5:00 p.m., (EDT). 

Place: Teleconference, Centers for Disease 

Control and Prevention, Room 1080, 8 

Corporate Square Blvd., Atlanta, GA 30329. 

Agenda: To review and evaluate grant 

applications. 

For Further Information Contact: Gregory 

Anderson, M.S., M.P.H., Scientific Review 

Officer, CDC, 1600 Clifton Road, NE, 

Mailstop E60, Atlanta, Georgia 30333, (404) 

718–8833, gca5@cdc.gov. 

The Chief Operating Officer, Centers for 

Disease Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for both 

the Centers for Disease Control and 


amozie on DSK3GDR082PROD with NOTICES1